WallStreetZenWallStreetZen

NASDAQ: ABVC
Abvc Biopharma Inc Stock

$0.79+0.00 (+0%)
Updated Jul 16, 2024
ABVC Price
$0.79
Fair Value Price
-$0.46
Market Cap
$8.57M
52 Week Low
$0.67
52 Week High
$6.87
P/E
-0.35x
P/B
1.1x
P/S
502.87x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.36k
Earnings
-$12.62M
Gross Margin
-854.5%
Operating Margin
-36,460.87%
Profit Margin
-49,777%
Debt to Equity
0.9
Operating Cash Flow
-$3M
Beta
0.38
Next Earnings
Aug 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ABVC Overview

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing drugs and medical devices derived from plants. The company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. ABVC was founded in 1990 and is headquartered in Fremont, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ABVC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ABVC ($0.79) is overvalued by 271.31% relative to our estimate of its Fair Value price of -$0.46 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ABVC ($0.79) is not significantly undervalued (271.31%) relative to our estimate of its Fair Value price of -$0.46 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ABVC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ABVC due diligence checks available for Premium users.

Be the first to know about important ABVC news, forecast changes, insider trades & much more!

ABVC News

Valuation

ABVC fair value

Fair Value of ABVC stock based on Discounted Cash Flow (DCF)
Price
$0.79
Fair Value
-$0.46
Undervalued by
271.33%
ABVC ($0.79) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ABVC ($0.79) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ABVC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ABVC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.35x
Industry
-18x
Market
31.71x

ABVC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.1x
Industry
6.51x
ABVC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ABVC's financial health

Profit margin

Revenue
$1.2k
Net Income
-$3.9M
Profit Margin
-326,388%
ABVC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ABVC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$14.5M
Liabilities
$7.0M
Debt to equity
0.9
ABVC's short-term liabilities ($6.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ABVC's short-term assets ($1.79M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ABVC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$473.2k
Investing
$0.0
Financing
$676.2k
ABVC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ABVC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ABVC$8.57M-0.50%-0.35x1.10x
ADXN$8.48M-0.72%-56.58x-5.49x
ONVO$8.91M-8.55%-0.39x2.47x
KA$8.95M+1.39%-0.49x-1.40x
CYCN$7.99M+1.03%-73.75x0.81x

Abvc Biopharma Stock FAQ

What is Abvc Biopharma's quote symbol?

(NASDAQ: ABVC) Abvc Biopharma trades on the NASDAQ under the ticker symbol ABVC. Abvc Biopharma stock quotes can also be displayed as NASDAQ: ABVC.

If you're new to stock investing, here's how to buy Abvc Biopharma stock.

What is the 52 week high and low for Abvc Biopharma (NASDAQ: ABVC)?

(NASDAQ: ABVC) Abvc Biopharma's 52-week high was $6.87, and its 52-week low was $0.67. It is currently -88.5% from its 52-week high and 17.21% from its 52-week low.

How much is Abvc Biopharma stock worth today?

(NASDAQ: ABVC) Abvc Biopharma currently has 10,851,823 outstanding shares. With Abvc Biopharma stock trading at $0.79 per share, the total value of Abvc Biopharma stock (market capitalization) is $8.57M.

Abvc Biopharma stock was originally listed at a price of $29.90 in Aug 3, 2021. If you had invested in Abvc Biopharma stock at $29.90, your return over the last 2 years would have been -97.36%, for an annualized return of -83.75% (not including any dividends or dividend reinvestments).

How much is Abvc Biopharma's stock price per share?

(NASDAQ: ABVC) Abvc Biopharma stock price per share is $0.79 today (as of Jul 16, 2024).

What is Abvc Biopharma's Market Cap?

(NASDAQ: ABVC) Abvc Biopharma's market cap is $8.57M, as of Jul 17, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Abvc Biopharma's market cap is calculated by multiplying ABVC's current stock price of $0.79 by ABVC's total outstanding shares of 10,851,823.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.